Literature DB >> 19711131

Analysis of contemporary trends in access to high-volume ovarian cancer surgical care.

Robert E Bristow1, Isha Puri, Teresa P Diaz-Montes, Robert L Giuntoli, Deborah K Armstrong.   

Abstract

BACKGROUND: Positive volume-outcome relationships exist for cancers treated with technically complex surgery, including ovarian cancer. However, contemporary patterns of primary surgical care for ovarian cancer according to hospital and surgeon case volume remain poorly defined.
METHODS: The Maryland Health Service Cost Review Commission database was accessed for annual hospital and surgeon primary ovarian cancer surgical case volume for 2001-2008 and evaluated for statistically significant trends in access to high-volume surgical care compared with the earlier period for 1990-2000. chi(2) and logistic regression analyses were used to evaluate for significant trends in case volume distribution over time as well as factors associated with access to high-volume care.
RESULTS: Overall, 2,475 primary ovarian cancer operations were performed by 472 surgeons at 43 hospitals. There was a statistically significant increase in the proportion of cases performed at high-volume centers from 22.8% in 1990-2000 to 61.1% in 2001-2008 (odds ratio = 5.30, 95% confidence interval = 4.68-6.00, P < .0001), while low-volume hospital case distribution decreased from 49.6 to 31.3%. Access to high-volume surgeons increased from 34.5% in 1990-2000 to 64.5% in 2001-2008 (odds ratio = 3.44, 95% confidence interval = 3.06-3.87, P < .0001), while the proportion of cases performed by low-volume surgeons decreased from 56.3 to 28.9%. After controlling for other variables, high-volume surgeons were significantly more likely to perform ovarian cancer surgery that included hysterectomy and staging/cytoreductive surgical procedures.
CONCLUSIONS: The proportions of ovarian cancer patients undergoing primary surgery at high volume centers and by high-volume surgeons increased statistically significantly from 1990-2000 to 2001-2008. Further investigation is necessary to determine factors contributing to this favorable trend.

Entities:  

Mesh:

Year:  2009        PMID: 19711131     DOI: 10.1245/s10434-009-0680-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  Chronic medical conditions and reproducibility of self-reported age at menopause among community-dwelling women.

Authors:  Heather F de Vries; Gina M Northington; Elise M Kaye; Hillary R Bogner
Journal:  Menopause       Date:  2011-12       Impact factor: 2.953

2.  Observed-to-expected ratio for adherence to treatment guidelines as a quality of care indicator for ovarian cancer.

Authors:  Valerie B Galvan-Turner; Jenny Chang; Argyrios Ziogas; Robert E Bristow
Journal:  Gynecol Oncol       Date:  2015-09-24       Impact factor: 5.482

3.  Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center.

Authors:  Britt K Erickson; Jovana Y Martin; Monjri M Shah; J Michael Straughn; Charles A Leath
Journal:  Gynecol Oncol       Date:  2014-02-08       Impact factor: 5.482

4.  Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer Database.

Authors:  J Alejandro Rauh-Hain; Alexander Melamed; Alexi Wright; Allison Gockley; Joel T Clemmer; John O Schorge; Marcela G Del Carmen; Nancy L Keating
Journal:  JAMA Oncol       Date:  2017-01-01       Impact factor: 31.777

5.  Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer.

Authors:  Myong Cheol Lim; Heong Jong Yoo; Yong Jung Song; Sang Soo Seo; Sokbom Kang; Sun Ho Kim; Chong Woo Yoo; Sang Yoon Park
Journal:  J Gynecol Oncol       Date:  2017-07       Impact factor: 4.401

6.  Enhancing ovarian cancer care: a systematic review of guideline adherence and clinical variation.

Authors:  Kahren M White; Holly Seale; Reema Harrison
Journal:  BMC Public Health       Date:  2019-03-12       Impact factor: 3.295

7.  Practice patterns, attitudes, and knowledge among clinicians regarding hyperthermic intraperitoneal chemotherapy and pressurized intraperitoneal aerosol chemotherapy: a national survey by Indian society of peritoneal surface malignancies (ISPSM).

Authors:  Sampige Prasanna Somashekhar; Kumar C Rohit; S V S Deo; Kyatsandra Rajagopal Ashwin
Journal:  Pleura Peritoneum       Date:  2020-08-31

8.  Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons.

Authors:  Heon Jong Yoo; Jenny J Hong; Young Bok Ko; Mina Lee; Youjin Kim; Hye Young Han; Yong Jung Song; Myong Cheol Lim; Sang-Yoon Park
Journal:  World J Surg Oncol       Date:  2018-05-15       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.